Who owns ORIC?
Institutional ownership of Oric Pharmaceuticals Inc. from Form 13F, Q2 2026
181 institutional managers reported holding Oric Pharmaceuticals Inc. (ORIC) in Form 13F filings for Q2 2026, with 123,549,452 shares worth $1.3B. The largest reported holder was Nextech Invest Ltd. Managers that filed both quarters added a net 4,170,839 shares (+3.5%). 29 opened new positions and 30 sold out.
- Funds holding
- 181
- Value held
- $1.3B
- New / sold out
- 29 / 30
- Net shares, same filers
- +3.5%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ORIC
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Nextech Invest Ltd. | $77.6M | 5.8% | 7,162,637 | Unchanged |
| BlackRock, Inc. | $73.9M | 5.5% | 6,823,973 | Added |
| EcoR1 Capital, LLC | $72.9M | 5.4% | 6,728,116 | Unchanged |
| Price T Rowe Associates Inc | $71.7M | 5.4% | 6,617,554 | Added |
| Viking Global Investors LP | $55.5M | 4.1% | 5,126,762 | Trimmed |
| State Street Corp | $53.0M | 4.0% | 4,894,000 | Added |
| SR One Capital Management, LP | $50.0M | 3.7% | 4,615,384 | Added |
| Venrock Adviser, LLC | $46.8M | 3.5% | 4,319,765 | Unchanged |
| NEA Management Company, LLC | $44.6M | 3.3% | 4,118,621 | Unchanged |
| Vanguard Capital Management LLC | $42.8M | 3.2% | 3,951,169 | Added |
| AIHC Capital Management Ltd | $41.5M | 3.1% | 3,828,460 | Added |
| Alkeon Capital Management LLC | $40.5M | 3.0% | 3,739,096 | Trimmed |
| Column Group LLC | $38.3M | 2.9% | 3,540,777 | Unchanged |
| Siren, L.L.C. | $32.5M | 2.4% | 2,998,192 | Unchanged |
| FMR LLC | $28.5M | 2.1% | 2,635,475 | Added |
| Citadel Advisors LLC | $28.1M | 2.1% | 2,595,299 | Added |
| Goldman Sachs Group Inc | $26.6M | 2.0% | 2,451,796 | Added |
| Geode Capital Management, LLC | $22.6M | 1.7% | 2,090,089 | Added |
| First Turn Management, LLC | $21.8M | 1.6% | 2,017,284 | Unchanged |
| Orbimed Advisors LLC | $21.8M | 1.6% | 2,015,000 | Trimmed |
| Integral Health Asset Management, LLC | $20.6M | 1.5% | 1,900,000 | Added |
| MPM Bioimpact LLC | $20.4M | 1.5% | 1,882,162 | Added |
| Vivo Capital, LLC | $20.0M | 1.5% | 1,848,786 | Unchanged |
| Dimensional Fund Advisors LP | $19.5M | 1.5% | 1,801,399 | Added |
| Franklin Resources Inc | $19.5M | 1.5% | 1,797,377 | Added |
Share of 13F holdings is each fund's shares as a share of the 123,549,452 ORIC shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- D. E. Shaw & Co., Inc. Added+$16.6M
- AIHC Capital Management Ltd Added+$14.8M
- Price T Rowe Associates Inc Added+$13.3M
- State Street Corp Added+$12.9M
- Algert Global LLC Added+$11.7M
- Goldman Sachs Group Inc Added+$10.6M
- BlackRock, Inc. Added+$9.1M
- Jones Hill Capital LP New+$8.1M
- Adage Capital Partners GP, L.l.c. Added+$7.7M
- Millennium Management LLC Added+$7.2M
Biggest sellers in Q2 2026
- Pfizer Inc Trimmed-$42.0M
- Paradigm Biocapital Advisors LP Sold out-$21.6M
- Logos Global Management LP Sold out-$12.0M
- Sofinnova Investments, Inc. Sold out-$8.6M
- Alkeon Capital Management LLC Trimmed-$8.3M
- Viking Global Investors LP Trimmed-$7.6M
- Orbimed Advisors LLC Trimmed-$7.4M
- Lord, Abbett & Co. LLC Sold out-$6.9M
- Polar Capital Holdings Plc Sold out-$6.8M
- Balyasny Asset Management L.P. Trimmed-$5.4M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $199M and sold $158M; 82 added and 42 trimmed.
Schedule 13D and 13G filings on ORIC
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15PRICE T ROWE ASSOCIATES INC /MD/ SCHEDULE 13G filed by Oric Pharmaceuticals Inc.Schedule 13G
- 2026-01-21BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-08-05EcoR1 Capital, LLC SCHEDULE 13G filed by Oric Pharmaceuticals Inc.Schedule 13G
- 2025-06-04Point72 Asset Management, L.P. SCHEDULE 13G filed by Oric Pharmaceuticals Inc.Schedule 13G
- 2025-05-30Venrock Healthcare Capital Partners III, L.P. SCHEDULE 13G filed by Oric Pharmaceuticals Inc.Schedule 13G
Questions about ORIC ownership
- Who owns ORIC stock?
- 181 institutional investment managers reported ORIC positions in their Form 13F filings for Q2 2026, holding 123,549,452 shares worth $1.3B in total. Nextech Invest Ltd. reported the largest position.
- Are funds buying or selling ORIC?
- In Q2 2026, 29 managers opened new ORIC positions, 82 added, 42 trimmed and 30 sold out. Managers that filed in both quarters added a net 4,170,839 shares.
- How current is this ORIC institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ORIC by CUSIP. Options are left out. ORIC news and filings · ORIC insider trades · Top funds